191 related articles for article (PubMed ID: 26473854)
1. G Protein-Coupled Receptor 87 (GPR87) Promotes Cell Proliferation in Human Bladder Cancer Cells.
Zhang X; Liu D; Hayashida Y; Okazoe H; Hashimoto T; Ueda N; Sugimoto M; Kakehi Y
Int J Mol Sci; 2015 Oct; 16(10):24319-31. PubMed ID: 26473854
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Cell-surface Molecular GPR87 With GPR87-suppressing Adenoviral Vector Disturb Tumor Proliferation in Lung Cancer Cells.
Kita Y; Go T; Nakashima N; Liu D; Tokunaga Y; Zhang X; Nakano T; Nii K; Chang SS; Yokomise H
Anticancer Res; 2020 Feb; 40(2):733-741. PubMed ID: 32014915
[TBL] [Abstract][Full Text] [Related]
3. Expression and role of GPR87 in urothelial carcinoma of the bladder.
Okazoe H; Zhang X; Liu D; Shibuya S; Ueda N; Sugimoto M; Kakehi Y
Int J Mol Sci; 2013 Jun; 14(6):12367-79. PubMed ID: 23752273
[TBL] [Abstract][Full Text] [Related]
4. The G protein-coupled receptor 87 is necessary for p53-dependent cell survival in response to genotoxic stress.
Zhang Y; Qian Y; Lu W; Chen X
Cancer Res; 2009 Aug; 69(15):6049-56. PubMed ID: 19602589
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of G protein-coupled receptor GPR87 promotes pancreatic cancer aggressiveness and activates NF-κB signaling pathway.
Wang L; Zhou W; Zhong Y; Huo Y; Fan P; Zhan S; Xiao J; Jin X; Gou S; Yin T; Wu H; Liu T
Mol Cancer; 2017 Mar; 16(1):61. PubMed ID: 28288630
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of RRM1 with Adenoviral shRNA Vectors to Inhibit Tumor Cell Viability and Increase Chemotherapeutic Sensitivity to Gemcitabine in Bladder Cancer Cells.
Zhang X; Taoka R; Liu D; Matsuoka Y; Tohi Y; Kakehi Y; Sugimoto M
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921102
[TBL] [Abstract][Full Text] [Related]
7. Dicoumarol enhances doxorubicin-induced cytotoxicity in p53 wild-type urothelial cancer cells through p38 activation.
Matsui Y; Watanabe J; Ding S; Nishizawa K; Kajita Y; Ichioka K; Saito R; Kobayashi T; Ogawa O; Nishiyama H
BJU Int; 2010 Feb; 105(4):558-64. PubMed ID: 19583730
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of STAT signalling in bladder cancer by diindolylmethane: relevance to cell adhesion, migration and proliferation.
Sun Y; Cheng MK; Griffiths TR; Mellon JK; Kai B; Kriajevska M; Manson MM
Curr Cancer Drug Targets; 2013 Jan; 13(1):57-68. PubMed ID: 22920439
[TBL] [Abstract][Full Text] [Related]
9. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
10. Co-transduction of ribosomal protein L23 enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in human gastric cancer.
Zhang YF; Zhang BC; Zhang AR; Wu TT; Liu J; Yu LF; Wang WX; Gao JF; Fang DC; Rao ZG
Oncol Rep; 2013 Oct; 30(4):1989-95. PubMed ID: 23933826
[TBL] [Abstract][Full Text] [Related]
11. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
12. Targeted p53 activation by saRNA suppresses human bladder cancer cells growth and metastasis.
Wang C; Ge Q; Zhang Q; Chen Z; Hu J; Li F; Ye Z
J Exp Clin Cancer Res; 2016 Mar; 35():53. PubMed ID: 27012825
[TBL] [Abstract][Full Text] [Related]
13. Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53.
Tang Y; Simoneau AR; Xie J; Shahandeh B; Zi X
Cancer Prev Res (Phila); 2008 Nov; 1(6):439-51. PubMed ID: 19138991
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral vector expressing short hairpin RNA targeting Wnt2B has an effective antitumour activity against Wnt2B2-overexpressing tumours.
Liu D; Kadota K; Ueno M; Nakashima N; Yokomise H; Huang CL
Eur J Cancer; 2012 May; 48(8):1208-18. PubMed ID: 21646015
[TBL] [Abstract][Full Text] [Related]
15. Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin.
Pagliaro LC; Keyhani A; Liu B; Perrotte P; Wilson D; Dinney CP
Urol Oncol; 2003; 21(6):456-62. PubMed ID: 14693272
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor Angiogenesis.
Xu M; Xie Y; Sheng W; Miao J; Yang J
Technol Cancer Res Treat; 2015 Oct; 14(5):617-26. PubMed ID: 24750000
[TBL] [Abstract][Full Text] [Related]
17. FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth.
Du X; Wang QR; Chan E; Merchant M; Liu J; French D; Ashkenazi A; Qing J
Cancer Res; 2012 Nov; 72(22):5843-55. PubMed ID: 23019225
[TBL] [Abstract][Full Text] [Related]
18. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
[TBL] [Abstract][Full Text] [Related]
19. Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression.
Zheng Y; Ishiguro H; Ide H; Inoue S; Kashiwagi E; Kawahara T; Jalalizadeh M; Reis LO; Miyamoto H
Mol Endocrinol; 2015 Oct; 29(10):1486-97. PubMed ID: 26322830
[TBL] [Abstract][Full Text] [Related]
20. Functional analyses and prognostic significance of SFRP1 expression in bladder cancer.
Rogler A; Kendziorra E; Giedl J; Stoehr C; Taubert H; Goebell PJ; Wullich B; Stöckle M; Lehmann J; Petsch S; Hartmann A; Stoehr R
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1779-90. PubMed ID: 25732201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
